MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, SRTS had $2,291K increase in cash & cash equivalents over the period. $2,291K in free cash flow.

Cash Flow Overview

Change in Cash
$2,291K
Free Cash flow
$2,291K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
2025-06-30
Net (loss) income
-943 -3,609
Credit loss expense
44 0
Depreciation
98 185
Amortization of right-of-use asset
61 118
Provision for product warranties
-268 -138
Stock-based compensation
73 146
Income tax payable
-0
Deferred income taxes
-1,427 -613
Accounts receivable
-3,242 -7,109
Inventories
537 3,176
Prepaid inventory
-1,340 -666
Other current assets
-314 842
Other noncurrent assets
283 -117
Accounts payable and accrued expenses
254 554
Operating lease liability
-61 -118
Deferred revenue
108 -35
Product warranties
256 200
Net cash provided by (used in) operating activities
2,295 440
Acquisition of property and equipment
4 34
Net cash used in investing activities
-4 -34
Exercise of stock options
-0
Repurchase of common stock
0 300
Net cash used in financing activities
0 -300
Net increase (decrease) in cash and cash equivalents
2,291 106
Cash and cash equivalents at beginning of period
22,056 -
Cash and cash equivalents at end of period
24,453 -
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Sensus Healthcare, Inc. (SRTS)

Sensus Healthcare, Inc. (SRTS)